Clinical Trial Update: Autologous, Micro-fragmented Adipose Tissue for Meniscal Tears [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous micro-fragmented adipose tissue for meniscal tears and knee conditions has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee
• Tibial Meniscus Injuries

Drugs mentioned

• Autologous micro-fragmented adipose tissue (autologous micro-fragmented adipose tissue)

Snippet

Sponsor: New Jersey Regenerative Institute, LLC | Conditions: Tibial Meniscus Injuries, Osteoarthritis, Knee | Phase 2 | Status: COMPLETED | Results posted: 2019-09-11